Literature DB >> 32298762

Overexpression of NuSAP1 is predictive of an unfavourable prognosis and promotes proliferation and invasion of triple-negative breast cancer cells via the Wnt/β-catenin/EMT signalling axis.

Li Sun1, Changlong Shi2, Shaozhuang Liu2, Enchong Zhang2, Long Yan3, Ce Ji4, Yi Zhao5.   

Abstract

OBJECTIVE: We analysed the effect of expression of nucleolar spindle-associated protein 1 (NuSAP1) on the prognosis of breast cancer (BC) and investigated its potential mechanism of tumourigenicity in triple-negative breast cancer (TNBC) cell lines.
MATERIALS AND METHODS: We downloaded the RNA-seq breast cancer (BC) data from The Cancer Genome Atlas (TCGA) and screened for the NuSAP1 gene using R software. The clinical data for patients with BC were screened and analysed using R software. A survival curve was drawn using the Kaplan-Meier Plotter. Cell proliferation and invasion were verified by the Cell Counting Kit-8 and Transwell assays. Expression of NuSAP1, the Wnt/β-catenin pathway, and epithelial-mesenchymal-transition-related proteins in TNBC was detected using real-time quantitative polymerase chain reaction (qRT-PCR) and western blotting (WB).
RESULTS: Expression of NuSAP1 was upregulated in BC. The change in NuSAP1 expression levels was associated with multiple clinicopathological factors, and the higher the expression of NuSAP1 was, the shorter the survival time. In MDA-MB-231 and BT549 cells, knockdown of NuSAP1 expression resulted in a significant decrease in cell proliferation and invasion; a decrease in expression of cyclin D1, vimentin, Slug, Twist, wnt3a, and pβ-catenin; and an increase in expression of e-cadherin. The results of the sh-NuSAP1 + ov-NuSPA1 group were the opposite of the results of the sh-NuSAP1 group.
CONCLUSION: NuSAP1 is a carcinogen that facilitates progression of TNBC through the Wnt/β-catenin and epithelial-mesenchymal transition pathways.
Copyright © 2020. Published by Elsevier B.V.

Entities:  

Keywords:  Cell invasion; Cell proliferation; EMT; NuSAP1; Triple-negative breast cancer; Wnt/β-catenin pathway

Year:  2020        PMID: 32298762     DOI: 10.1016/j.gene.2020.144657

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  11 in total

1.  Evaluate the diagnostic and prognostic value of NUSAP1 in papillary thyroid carcinoma and identify the relationship with genes, proteins, and immune factors.

Authors:  Tiantian Gao; Lei Zhao; Fan Zhang; Conghui Cao; Shuting Fan; Xiaoguang Shi
Journal:  World J Surg Oncol       Date:  2022-06-16       Impact factor: 3.253

2.  Transcription factor HOXB2 upregulates NUSAP1 to promote the proliferation, invasion and migration of nephroblastoma cells via the PI3K/Akt signaling pathway.

Authors:  Bo Luo; Shasha Feng; Tianliang Li; Jun Wang; Zhaoyang Qi; Yi Zhao; Bo Hu
Journal:  Mol Med Rep       Date:  2022-04-29       Impact factor: 3.423

3.  Screening a Prognosis-Related Target Gene in Patients with HER-2-Positive Breast Cancer by Bioinformatics Analysis.

Authors:  Song Wang; Jian Deng; Xudong Gao; Hongying Lv; Yi Quan
Journal:  Med Princ Pract       Date:  2021-04-06       Impact factor: 1.927

4.  NUSAP1 promotes the metastasis of breast cancer cells via the AMPK/PPARγ signaling pathway.

Authors:  Juanjuan Qiu; Li Xu; Xiaohong Zeng; Zhenru Wu; Yu Wang; Yao Wang; Jiqiao Yang; Hao Wu; Yanyan Xie; Faqing Liang; Qing Lv; Zhenggui Du
Journal:  Ann Transl Med       Date:  2021-11

5.  Increased NUSAP1 expression is associated with lymph node metastasis and survival prognosis in bladder urothelial carcinoma.

Authors:  Jian Hou; Zhenquan Lu; Xianhua Liu; Bingfeng Luo; Genyi Qu; Yong Xu; Cheng Tang
Journal:  Sci Rep       Date:  2022-04-29       Impact factor: 4.379

6.  Kindlins as modulators of breast cancer progression.

Authors:  Edward F Plow; Elzbieta Pluskota; Katarzyna Bialkowska
Journal:  J Breast Cancer Res       Date:  2021

7.  Dual role of WNT5A in promoting endothelial differentiation of glioma stem cells and angiogenesis of glioma derived endothelial cells.

Authors:  Taoliang Chen; Fabing Zhang; Jie Liu; Zhilin Huang; Yaofeng Zheng; Shaokang Deng; Yang Liu; Jihui Wang; Xinlin Sun
Journal:  Oncogene       Date:  2021-06-29       Impact factor: 9.867

8.  Progress in Natural Compounds/siRNA Co-delivery Employing Nanovehicles for Cancer Therapy.

Authors:  Milad Ashrafizadeh; Ali Zarrabi; Kiavash Hushmandi; Farid Hashemi; Ebrahim Rahmani Moghadam; Mehdi Raei; Mahshad Kalantari; Shima Tavakol; Reza Mohammadinejad; Masoud Najafi; Franklin R Tay; Pooyan Makvandi
Journal:  ACS Comb Sci       Date:  2020-10-23       Impact factor: 3.784

9.  Cyclin B2 (CCNB2) Stimulates the Proliferation of Triple-Negative Breast Cancer (TNBC) Cells In Vitro and In Vivo.

Authors:  Shuai Wu; Rui Su; Hongyan Jia
Journal:  Dis Markers       Date:  2021-07-26       Impact factor: 3.434

10.  Construction and analysis of the abnormal lncRNA-miRNA-mRNA network in hypoxic pulmonary hypertension.

Authors:  Jie Liu; Yishu Deng; Zeqin Fan; Shuanglan Xu; Li Wei; Xiaoxian Huang; Xiqian Xing; Jiao Yang
Journal:  Biosci Rep       Date:  2021-08-27       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.